Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interventions for Convergence Insufficiency in Concussed Children (ICONICC)

NCT03908112 is registered in ClinicalTrials.gov with Mitchell Scheiman as lead sponsor.

NCT NCT03908112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03908112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interventions for Convergence Insufficiency in Concussed Children (ICONICC)
Lead sponsor
Mitchell Scheiman
Phase
Phase 3
Overall status
Unknown status
Start date
April 1, 2021
Completion date
March 31, 2025
Enrollment
264 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

concussion, convergence insufficiency